NewsRoom Articles - Page 76 of 592

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

TuesdayNov 14, 2023 4:20 am

420 with CNW — Nevada Approves Six Additional Cannabis Consumption Lounges

Nevada authorities are still granting more licenses for consumption lounges, with the state’s marijuana compliance board (CCB) recently giving the green light to six additional conditional licenses for various marijuana businesses, including TGIG LLC; NevadaPure LLC; Higher* Archy LLC; Desert Evolution LLC; Green Thumb Industries (GTI); and Curaleaf Holdings. Curaleaf Holdings, a global cannabis giant, obtained one license for Tryke Companies, its subsidiary that runs Reef Dispensaries. GTI, another significant player in the multistate marijuana sector, also secured a license for Integral Associates, its subsidiary, with intentions to open a club on the Strip. The CCB stated in June last…

MondayNov 13, 2023 4:20 pm

420 with CNW — Cannabis Firms Uplist Stocks in Canada in Preparation for US Listing

Multiple marijuana multistate operators (MSOs) are elevating their stock listings in Canada to higher-tier exchanges, setting a trend that more are likely to follow. However, their main objective appears to be listing on U.S. exchanges such as the NASDAQ or the New York Stock Exchange (NYSE). The shift involves MSOs moving from the lower Canadian Securities Exchange (CSE) to the Cboe Canada Exchange or the Toronto Stock Exchange (TSX). This transition holds potential advantages, including increased liquidity and trading volume, access to institutional investments, and meeting stricter listing requirements, aligning these companies closer to conditions necessary for listing on the…

MondayNov 13, 2023 4:20 am

420 with CNW — Bipartisan Bill to Legalize Cannabis Federally Is Reintroduced in Congress

A Republican has reintroduced a bipartisan measure that would legalize cannabis at the federal level to Congress. South Carolina Republican Representative Nancy Mace reintroduced the States Reform Act, a measure to amend the federal Controlled Substances Act and allow cannabis at the federal level. The proposal is currently acting as a placeholder and has no text. Even so, it is cosponsored by Republican Representatives Matt Gaetz (Florida) and Tom McClintock (California) as well as Democratic Representatives Dean Phillips (Minnesota) and David Trone (Maryland). Democrats have largely been behind America’s decade-long wave of cannabis reform and are currently working to legalize…

FridayNov 10, 2023 4:20 pm

420 with CNW — Study Shows Opioid Prescription Rates Reduce When Patients Can Legally Access CBD

A recent study investigating the impact of CBD availability on opioid prescriptions has revealed that although legalizing CBD alone does not automatically reduce the rate of opioid prescriptions, making legal CBD products readily available and affordable has significantly reduced the number of opioid prescriptions by approximately 8.1%. The study, which was recently published in the “Journal of Southern Economics,” suggests that three key factors impact the opioid crisis: prescription CBD legalization, regulations that limit CBD purchases and access through CBD dispensaries. To conduct the study, the authors scrutinized state laws concerning restricted-access, CBD-only regulations in states such as Texas, Iowa…

FridayNov 10, 2023 4:20 am

420 with CNW — Study Finds Higher Increase in Home Valuations in Legal States vs. Cannabis Prohibitionist States

Home values in states with legal cannabis markets have grown at significantly faster rates over the past decade compared to prohibitionist states. According to a Leafly and Real Estate Witch study, homes in cannabis states are 41% higher in value than homes in states without legal cannabis markets. The paper looked at the potential impact of recreational or medical cannabis markets on average American home prices from 2014–2023. Although states such as California began legalizing medical cannabis more than a decade ago, the past decade has seen a multitude of states legalize the controversial plant. With dozens of states now…

ThursdayNov 09, 2023 4:20 pm

420 with CNW — Study Predicts $260M Addition to Ohio’s Economy After Cannabis Legalization

Despite differing opinions among ardent supporters, cannabis legalization in Ohio could entail certain drawbacks. Nonetheless, an economic analysis published last week suggests that the advantages would surpass these drawbacks by a yearly sum of $250 million. Issue 2, a proposal to legalize recreational cannabis in Ohio, is set for the upcoming election on Tuesday. A study conducted by Scioto Analysis sought to assess the potential benefits and drawbacks of such a step in a state where medical cannabis is already legal. To conduct the analysis, the research group drew on findings from states such as Colorado and Washington, where recreational…

ThursdayNov 09, 2023 4:20 am

420 with CNW — Connecticut Doubles Recreational Cannabis Purchase Limit

Beginning in December, adults in the state of Connecticut will be allowed to buy up to one-half an ounce of cannabis in one retail transaction. This comes after the state doubled its purchase limit from quarter of an ounce of marijuana. The state’s Department of Consumer Protection announced the scheduled increase last week, explaining that it was the result of a continuing analysis of demand and supply and was designed to make certain businesses maintain sufficient supply for both medical cannabis patients and adult-use consumers. It should be noted, however, that the limits imposed on medical cannabis remain unchanged. The…

WednesdayNov 08, 2023 4:20 pm

420 with CNW — University of Buffalo Professor Receives $3.2M Grant to Study Cannabis Among Cancer Patients

The National Institutes of Health's (NIH) National Cancer Institute has allocated $3.2 million to fund a study exploring the impact of marijuana use on cancer patients undergoing immunotherapy treatment. The grant, announced by the University of Buffalo (UB), aims to conduct a comprehensive yearlong examination of how cannabis use by cancer patients affects their response to conventional cancer treatments. Specifically, the study focuses on patients undergoing immunotherapy, a treatment known for its reduced side effects compared to chemotherapy. Speaking at a National Academies of Sciences, Engineering, and Medicine (NASEM) meeting last month, an NCI representative expressed the organization's desire to…

WednesdayNov 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Patented DehydraTECH(TM) Technology’s Effectiveness on GLP-1 Drugs for Potential Diabetes Treatment and Weight Loss

Lexaria, a global innovator in drug delivery platforms, recently announced plans to launch new human and animal studies examining whether its patented DehydraTECH(TM) technology can make GLP-1 drugs better Lexaria has previously demonstrated DehydraTECH’s overall potential in its DIAB-A22-1 animal study, which yielded weight loss, and improved triglyceride and cholesterol levels among diabetic-conditioned animals The company plans to replicate the results from this study while also exploring ways to improve the overall bioavailability of GLP-1 drugs for diabetes treatment and weight loss Lexaria management is optimistic that it will build on previous studies, replicate previous positive results, and improve the…

News and publishing service for cannabis related companies

Contact us: 512.354.7000